264 related articles for article (PubMed ID: 12892952)
1. TRIPS: whose interests are being served?
Kamal M; Bailey M
Lancet; 2003 Jul; 362(9380):260. PubMed ID: 12892952
[No Abstract] [Full Text] [Related]
2. WTO takes a first step.
Lancet; 2003 Sep; 362(9386):753. PubMed ID: 13678862
[No Abstract] [Full Text] [Related]
3. TRIPS AGREEMENT ARTICLE 31(B): THE NEED FOR REVISION.
Effingham AM
Seton Hall Law Rev; 2016; 46(3):883-909. PubMed ID: 27066613
[No Abstract] [Full Text] [Related]
4. TRIPS: generic irony.
Howarth GR
Br J Gen Pract; 2002 Jan; 52(474):57. PubMed ID: 11791819
[No Abstract] [Full Text] [Related]
5. Trade deal to curb generic-drug use.
Maxmen A
Nature; 2012 Sep; 489(7414):16-7. PubMed ID: 22962700
[No Abstract] [Full Text] [Related]
6. Potential conflict between TRIPS and GATT concerning parallel importation of drugs and possible solution to prevent undesirable market segmentation.
Lo CF
Food Drug Law J; 2011; 66(1):73-83, ii. PubMed ID: 24505847
[TBL] [Abstract][Full Text] [Related]
7. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
[TBL] [Abstract][Full Text] [Related]
8. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
Curti AM
Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145
[No Abstract] [Full Text] [Related]
9. Impact of India's new patents law 2005: a physician's perspective.
Lele RD
J Assoc Physicians India; 2005 Aug; 53():671-5. PubMed ID: 16398073
[No Abstract] [Full Text] [Related]
10. [Essential medicines and the TRIPS Agreement: collision between the right to health and intellectual property rights].
Allard Soto R
Salud Colect; 2015 Mar; 11(1):9-21. PubMed ID: 25853827
[TBL] [Abstract][Full Text] [Related]
11. Why are generic drugs being held up in transit? Intellectual property rights, international trade, and the right to health in Brazil and beyond.
Rosina MS; Shaver L
J Law Med Ethics; 2012; 40(2):197-205. PubMed ID: 22789040
[TBL] [Abstract][Full Text] [Related]
12. Canada to change patent law to allow export of cheap drugs.
Kondro W
Lancet; 2003 Oct; 362(9392):1290. PubMed ID: 14577437
[No Abstract] [Full Text] [Related]
13. Impact of the World Trade Organization TRIPS agreement on the pharmaceutical industry in Thailand.
Supakankunti S; Janjaroen WS; Tangphao O; Ratanawijitrasin S; Kraipornsak P; Pradithavanij P
Bull World Health Organ; 2001; 79(5):461-70. PubMed ID: 11417042
[TBL] [Abstract][Full Text] [Related]
14. Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere.
Baker BK
PLoS Med; 2016 Mar; 13(3):e1001970. PubMed ID: 26954325
[TBL] [Abstract][Full Text] [Related]
15. Undermining TRIPS: protectionism at its worst.
Lancet; 2007 Jan; 369(9555):2. PubMed ID: 17208619
[No Abstract] [Full Text] [Related]
16. USA-Morocco deal may extend drug patents to 30 years.
Ahmad K
Lancet; 2003 Dec; 362(9399):1904. PubMed ID: 14672079
[No Abstract] [Full Text] [Related]
17. Changes to intellectual property policy in South Africa: putting a stop to evergreening?
Hill JE
Expert Opin Ther Pat; 2014 Aug; 24(8):839-43. PubMed ID: 24965317
[TBL] [Abstract][Full Text] [Related]
18. The new patent regime and disease priorities in India.
Gupta I; Guin P; Trivedi M
Glob Public Health; 2013; 8(1):37-54. PubMed ID: 22845021
[TBL] [Abstract][Full Text] [Related]
19. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
Spectar JM
Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
[No Abstract] [Full Text] [Related]
20. Unfair competition under the TRIPS agreement: protection of data submitted for the registration of pharmaceuticals.
Correa CM
Chic J Int Law; 2002; 3(1):69-85. PubMed ID: 15709300
[No Abstract] [Full Text] [Related]
[Next] [New Search]